Case Report (n=2)
Gross total resection with adjuvant radiation and chemotherapy is the recommended approach for rare primary angiosarcoma of the brain.
May support multimodal therapy in primary CNS angiosarcoma; hypothesis-generating from two cases and should not yet change practice.
INTRODUCTION: Primary angiosarcoma of the brain is extremely rare; only 15 cases have been reported in adults over the last 25 years. CASE PRESENTATIONS: We describe two cases of primary angiosarcoma of the brain that are well characterized by imaging, histopathology, and immunohistochemistry. Case 1: our first patient was a 35-year-old woman who developed exophthalmos. Subtotal resection of a left extra-axial retro-orbital mass was performed. Case 2: our second patient was a 47-year-old man who presented to our facility with acute visual loss, word-finding difficulty and subtle memory loss. A heterogeneously-enhancing left sphenoid wing mass was removed. We also review the literature aiming at developing a rational approach to diagnosis and treatment, given the rarity of this entity. CONCLUSIONS: Gross total resection is the standard of care for primary angiosarcoma of the brain. Adjuvant radiation and chemotherapy are playing increasingly recognized roles in the therapy of these rare tumors.
No takes yet. Share an insight, caveat, or question.
Hackney et al. (2012) conducted a case report in Primary central nervous system angiosarcoma (n=2). Surgical resection and adjuvant therapy (radiation, bevacizumab, temozolomide) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: